The relationship between the haemoglobin concentration and the haematocrit in Plasmodium falciparum malaria
- Sue J Lee1,
- Kasia Stepniewska1,
- Nicholas Anstey2,
- Elizabeth Ashley3,
- Karen Barnes4,
- Tran Quang Binh5,
- Umberto D'Alessandro6,
- Nicholas PJ Day1, 7,
- Peter J de Vries8,
- Grant Dorsey9, 10, 11,
- Jean-Paul Guthmann12,
- Mayfong Mayxay13, 14,
- Paul Newton14,
- Francois Nosten3,
- Piero Olliaro7, 15,
- Lyda Osario16,
- Loretxu Pinoges12,
- Ric Price3,
- Mark Rowland17,
- Frank Smithuis18,
- Robert Taylor15 and
- Nicholas J White1, 7Email author
© Lee et al; licensee BioMed Central Ltd. 2008
Received: 08 April 2008
Accepted: 02 August 2008
Published: 02 August 2008
Malaria is a very important cause of anaemia in tropical countries. Anaemia is assessed either by measurement of the haematocrit or the haemoglobin concentration. For comparisons across studies, it is often necessary to derive one measure from the other.
Data on patients with slide-confirmed uncomplicated falciparum malaria were pooled from 85 antimalarial drug trials conducted in 25 different countries, to assess the haemoglobin/haematocrit relationship at different time points in malaria. Using a linear random effects model, a conversion equation for haematocrit was derived based on 3,254 measurements from various time points (ranging from day 0 to day 63) from 1,810 patients with simultaneous measurements of both parameters. Haemoglobin was also estimated from haematocrit with the commonly used threefold conversion.
A good fit was obtained using Haematocrit = 5.62 + 2.60 * Haemoglobin. On average, haematocrit/3 levels were slightly higher than haemoglobin measurements with a mean difference (± SD) of -0.69 (± 1.3) for children under the age of 5 (n = 1,440 measurements from 449 patients).
Based on this large data set, an accurate and robust conversion factor both in acute malaria and in convalescence was obtained. The commonly used threefold conversion is also valid.
Malaria is a major cause of anaemia in tropical countries. It results from the obligatory destruction of parasitized erythrocytes, the accelerated destruction of normal erythrocytes, and variable dyserythropoiesis. Anaemia is assessed either by measurement of the haematocrit or the haemoglobin concentration. Clinical and epidemiological studies of malaria use either measure, so for comparisons across studies, it is often necessary to derive one measure from the other. Malaria is associated with increased acute phase protein concentrations and severe malaria increases erythrocyte rigidity, which may affect the relationship between haemoglobin and haematocrit. Recently, it has been suggested that the threefold conversion that is commonly used to equate the two measures (haemoglobin = haematocrit/3), consistently overestimates the haemoglobin concentration resulting in an underestimate of the prevalence of anaemia [1, 2].
This is important as anaemia is an important measure both of the efficacy of antimalarial treatment and the effectiveness of malaria control programmes. Data from patients with slide-confirmed, uncomplicated falciparum malaria were pooled from 85 antimalarial drug trials conducted in 25 different countries, to assess the haemoglobin/haematocrit relationship at different time points in malaria.
There were 78,239 haematocrit (Ht) measurements from 17,739 patients compared with 26,863 haemoglobin (Hb) measurements from 13,092 patients. The conversion equation for haematocrit was based on 3,254 measurements from various timepoints from 1,810 patients with simultaneous measurements of both parameters (mean Hb 10.5 g/dl, standard deviation (SD) 2.5 g/dl; mean Ht 33.0%, SD 7.1%). Post-treatment follow-up ranged from 14 to 63 days. Haematocrit was measured by centrifugation for 673 patients and by conductivity for 1,137 patients.
Because haematocrit or haemoglobin concentrations change during recovery from malaria, adjustment for time was included. The potential effect of age and sex on the haematocrit/haemoglobin relationship was also explored.
Results and discussion
As there was significant random variation within each individual as well as between individuals (Breusch and Pagan Lagrange multiplier test for random effects, p < 0.0001)  a linear random effects model was constructed using the equation:
Htit = α + Hbit * βhb + time * βtime + vi + eit (1)
(where Ht is haematocrit (%), Hb is haemoglobin (g/dL), vi is the random effect for each individual, i, β is the coefficient for each parameter that the model estimated, eit is the deviation for each individual, i, at time, t, and α is the intercept) and obtained: Ht = 5.66 + 2.58 * Hb + 0.01 * time which explained approximately 80% of the variance in the model (r2 (within) = 0.63, r2 (between) = 0.82, r2 (overall) = 0.83). Age and sex did not significantly improve the model fit (p = 0.22 and p = 0.17, respectively).
Although time contributed significantly to the model fit (95% CI 0.005, 0.023), its effect was very small. For example, a haematocrit value of 35.5% at day 0 would change to 35.78% (35.5 + 0.28) on day 28 if time were taken into account.
A simpified conversion without the time covariate using a random effects model gave:
Ht = 5.62 + 2.60 * Hb (2)
Using a Bland -Altman plot  to compare the values obtained using the conversion equation with the original observed values, the mean difference was -0.019 (95% CI -0.12 to 0.09) percentage points indicating that, overall, the predictions from the conversion equation tended to give slightly lower haematocrit estimates by up to 0.12 percentage points (Figure 1b). However, the conversion equation also overestimated haematocrit by up to 0.23 percentage points. Limits of agreement were calculated as the mean difference ± 1.96 SD and 94.3% of the values fell within these limits.
In summary, based on this large data set, the conversion factor to equate haemoglobin and haematocrit (Ht = 5.62 + 2.60 * Hb) is accurate and robust both in acute uncomplicated malaria and in convalescence. The two measures can be readily interconverted. The commonly used threefold conversion is also valid.
This study was funded by the UNICEF/UNDP/World Bank/WHO Special Programme on Research & Training in Tropical Diseases (TDR) [Grant A50977] and was part of the Wellcome Trust-Mahidol University-Oxford Tropical Medicine Research Programme.
The opinions expressed in this paper are those of the authors and may not reflect those of their employing organizations. PO is a staff member of the WHO and WRJT was a member at the time of the conduct of the study; the authors alone are responsible for the views expressed in this publication and they do not necessarily represent the decisions, policy or views of the WHO.
- Carneiro IA, Drakeley CJ, Owusu-Agyei S, Mmbando B, Chandramohan D: Haemoglobin and haematocrit: is the threefold conversion valid for assessing anaemia in malaria-endemic settings?. Malar J. 2007, 6: 67-10.1186/1475-2875-6-67.PubMed CentralView ArticlePubMedGoogle Scholar
- Rodriguez-Morales AJ, Sanchez E, Arria M, Vargas M, Piccolo C, Colina R, Franco-Paredes C: Haemoglobin and haematocrit: the threefold conversion is also non valid for assessing anaemia in Plasmodium vivax malaria-endemic settings. Malar J. 2007, 6: 166-10.1186/1475-2875-6-166.PubMed CentralView ArticlePubMedGoogle Scholar
- Breusch TS, Pagan AR: The Lagrange Multiplier Test and its Applications to Model Specification in Econometrics. The Review of Economic Studies. 1980, 47 (1): 239-253. 10.2307/2297111.View ArticleGoogle Scholar
- Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986, 1 (8476): 307-310.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.